Your browser doesn't support javascript.
loading
Dual-Responsive Enzyme-Polysaccharide Conjugate as a Nanocarrier System for Enzyme Prodrug Therapy.
Konhäuser, Matthias; Kannaujiya, Vinod Kumar; Kaltbeitzel, Jonas; Winterwerber, Pia; Böhm, Elena; Breitenbach, Benjamin; Wich, Peter R.
Afiliación
  • Konhäuser M; Institute of Pharmaceutical and Biomedicinal Sciences, Johannes Gutenberg-University Mainz, Staudingerweg 5, Mainz 55128, Germany.
  • Kannaujiya VK; School of Chemical Engineering, University of New South Wales, Science and Engineering Building, Sydney, NSW 2052, Australia.
  • Kaltbeitzel J; Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW 2052, Australia.
  • Winterwerber P; School of Chemical Engineering, University of New South Wales, Science and Engineering Building, Sydney, NSW 2052, Australia.
  • Böhm E; Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW 2052, Australia.
  • Breitenbach B; Institute of Pharmaceutical and Biomedicinal Sciences, Johannes Gutenberg-University Mainz, Staudingerweg 5, Mainz 55128, Germany.
  • Wich PR; Institute of Pharmaceutical and Biomedicinal Sciences, Johannes Gutenberg-University Mainz, Staudingerweg 5, Mainz 55128, Germany.
Biomacromolecules ; 24(5): 2138-2148, 2023 05 08.
Article en En | MEDLINE | ID: mdl-37079077
Biopolymer-based drug delivery systems have gained considerable attention in the field of nanomedicine. In this study, a protein-polysaccharide conjugate was synthesized by covalent conjugation of the enzyme horseradish peroxidase (HRP) with acetalated dextran (AcDex) via a thiol exchange reaction. The resulting bioconjugate shows a dual-responsive behavior in acidic and reductive environments to achieve a controlled release of drugs. The self-assembly of this amphiphilic HRP-AcDex conjugate allows the encapsulation of prodrug indole-3-acetic acid (IAA) into the hydrophobic polysaccharide core. Under slightly acidic conditions, the acetalated polysaccharide reverts to its native hydrophilic form, which triggers the disassembly of micellar nanoparticles and the release of the encapsulated prodrug. The conjugated HRP further activates the prodrug by oxidation of IAA into cytotoxic radicals, which leads to cellular apoptosis. The results indicate that the HRP-AcDex conjugate in combination with IAA has great potential to be used as a novel enzyme prodrug therapy for cancer treatment.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Antineoplásicos Idioma: En Revista: Biomacromolecules Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Antineoplásicos Idioma: En Revista: Biomacromolecules Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos